SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to the upcoming April 20th inclusion in the Nasdaq-100 Index, which has triggered a surge of institutional buying and massive interest from retail traders. The community is sharply divided between bulls chasing the parabolic AI-driven demand and bears warning of a potential bubble similar to past semiconductor sell-offs.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility as investors debate its long-term potential in AI infrastructure and enterprise cloud against broader concerns about high debt and shifting sentiment toward software stocks. While many in the community remain bullish on its massive RPO backlog and aggressive AI pivot, others are actively trading based on bearish technical patterns and skepticism regarding the pace of enterprise AI adoption.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing extreme volatility and parabolic price action driven by an intense short squeeze, as retail traders draw parallels to previous high-profile squeeze events. While bullish sentiment is fueled by the stock's massive momentum and high short interest, skeptical investors and short sellers are warning of a potential blow-off top, pointing to weak fundamentals and the possibility of management diluting shares via an at-the-market program.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors speculate on potential early FDA approval for Deramiocel, with community sentiment driven by optimism over a possible leadership change at the FDA's Center for Biologics Evaluation and Research. Shareholders are closely tracking institutional accumulation, recent insider activity, and company-led hiring as indicators that a major regulatory catalyst or partnership announcement could be imminent.

Maulcoin

Maulcoin is surging as investors rally behind a grassroots 'Mauler' community, characterized by aggressive social media promotion and a collective focus on reaching specific market cap milestones. The community remains highly active and committed to long-term holding, viewing the current momentum and growth rate as early-stage opportunities before broader chart adoption.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending as investors debate whether the stock is a deep-value opportunity or a long-term value trap, fueled by rumors of potential M&A activity and calls for stronger leadership from the new CEO. The community is actively discussing the company's aggressive share buybacks, recent partnerships with major social platforms, and persistent frustration over the stock's stagnant price performance despite strong free cash flow.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention following back-to-back announcements of a multi-year partnership with Anthropic and a major capacity expansion with Meta. Community sentiment remains polarized between traders capitalizing on the intense momentum and price volatility, and skeptics expressing concerns over the company's aggressive debt-funded growth strategy and ongoing capital raises.

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

ImageneBio Inc.

ImageneBio, Inc.

ImageneBio is generating significant investor attention as community members debate its long-term potential in the dermatology and hair-loss sectors following a recent private placement. While some traders are focused on short-term price action and potential momentum plays, others are actively analyzing the company's clinical trial updates and institutional holdings to gauge its valuation relative to its cash reserves.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor investors are currently locked in a volatile tug-of-war, with market participants aggressively debating whether recent surges in chip stocks represent a sustainable bull cycle or a bubble ripe for an inevitable collapse. The sentiment is heavily polarized as traders weigh geopolitical tensions in the Middle East and energy concerns against aggressive AI-driven optimism and liquidity flows.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in community sentiment as investors lean into its 2011 roots as the original Bitcoin parody, positioning it as a nostalgic yet serious long-term meme contender. The discourse is dominated by high-conviction holders who view the asset's long history as a unique differentiator from typical short-lived tokens, fueling active discussions about its potential to reach massive market valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CSPCY Phase 2 trial w/est Aug completion date NCT06220097: https://www.clinicaltrials.gov/study/NCT06220097 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Clinicaltrials

ClinicalTrials.gov

Sign up or log in to access Trial Tracker! This limited demo only displays Phase 3 trials with primary completion dates within the last 3 months for companies with a market cap less than $1B. FDA Tracker Membership unlocks all of the selection criteria to help you screen the full range of clinical trial catalysts.